Prescription drug · ANDA
Metoprolol succinate NDC 0615-7824
Metoprolol succinate 50 mg/1 · Tablet, Extended release · Oral · NCS HealthCare of KY, LLC dba Vangard Labs
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0615-7824-05 | 00615782405 | 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-7824-05)Marketed from Aug 20, 2014 | |
| 0615-7824-28 | 00615782428 | 28 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-7824-28)Marketed from Jan 27, 2025 | |
| 0615-7824-39 | 00615782439 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-7824-39)Marketed from Aug 20, 2014 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 50 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090617
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 0615-7824_03a7ffa9-1fe3-4844-8095-4d2945484441SPL ID 03a7ffa9-1fe3-4844-8095-4d2945484441SPL set ID c4fb991c-025c-4a1d-9766-4b62ad70b5feRxCUI 866427, 866436UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400615782405followed by a unit qualifier and the quantityPackage 00615-7824-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol succinate extended-release tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure. ( 1.3) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocar…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090617
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-7823 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | PD-Rx Pharmaceuticals, Inc. | 72789-284 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | AvPAK | 50268-541 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | AvPAK | 50268-540 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | Major Pharmaceuticals | 0904-6323 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | Quallent Pharmaceuticals Health LLC | 82009-113 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | Quallent Pharmaceuticals Health LLC | 82009-114 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-7117 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | A-S Medication Solutions | 50090-7118 |
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | Cardinal Health 107, LLC | 55154-4698 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | Dr. Reddy's Laboratories Limited | 55111-466 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | Northstar Rx LLC | 72603-142 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | Dr. Reddy's Laboratories Limited | 55111-467 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | Major Pharmaceuticals | 0904-6322 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | Northstar Rx LLC | 72603-143 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | PD-Rx Pharmaceuticals, Inc. | 43063-624 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | A-S Medication Solutions | 50090-7238 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | A-S Medication Solutions | 50090-7239 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | Dr. Reddy's Laboratories Inc | 75907-344 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Bryant Ranch Prepack | 71335-0149 |
Showing 20 of 32.